Skip to main content
Premium Trial:

Request an Annual Quote

OncoMethylome Raises 3.3M Euros, Bringing IPO Proceeds up to 25.3M Euros

NEW YORK (GenomeWeb News) - Following its initial public offering and Euronext listing on June 27, OncoMethylome Sciences said on Friday that it has raised an additional €3.3 million through the exercise of over-allotment option by Fortis and ING, the joint lead managers in the offering.
 
OncoMethylome granted the option on up to 440,000 new shares, at the IPO price of €7.5 per share.
 
As a result, the company's proceeds from the IPO total €25.3 million.

The Scan

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.

SpliceVault Portal Provides Look at RNA Splicing Changes Linked to Genetic Variants

The portal, described in Nature Genetics, houses variant-related messenger RNA splicing insights drawn from RNA sequencing data in nearly 335,700 samples — a set known as the 300K-RNA resource.

Automated Sequencing Pipeline Appears to Allow Rapid SARS-CoV-2 Lineage Detection in Nevada Study

Researchers in the Journal of Molecular Diagnostics describe and assess a Clear Labs Dx automated workflow, sequencing, and bioinformatic analysis method for quickly identifying SARS-CoV-2 lineages.

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.